E-Cigarettes' Respiratory Effects in Obese Youth
(RESEC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
To determine vaping behaviors and respiratory function in obese and nonobese youth e-cigarette users.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you must abstain from all tobacco and nicotine for at least 12 hours before lab sessions.
Are e-cigarettes safe for use in obese youth?
How does the treatment of e-cigarettes differ from other treatments for respiratory effects in obese youth?
E-cigarettes, unlike traditional treatments, are primarily used for smoking cessation or recreational purposes, but they can introduce harmful chemicals and irritants into the lungs, potentially worsening respiratory symptoms in youth. This treatment is unique because it involves inhaling aerosols that contain toxic substances, which can lead to respiratory issues and nicotine addiction, especially in adolescents.678910
Who Is on the Research Team?
Dharini M Bhammar, PhD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for young adults aged 21-25 who use e-cigarettes daily for at least the past three months. Participants must be willing to avoid all tobacco and nicotine for 12 hours before lab visits, attend five sessions up to four hours each, and can read and speak English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Vaping Session 1
Participants vape using their own e-cigarette device while vaping behaviors and respiratory functions are assessed
Vaping Session 2
Participants vape using the VUSE e-cigarette device while vaping behaviors and respiratory functions are assessed
Follow-up
Participants are monitored for any changes in respiratory function and vaping behaviors
What Are the Treatments Tested in This Trial?
Interventions
- ECIG own
- ECIG Vuse
ECIG own is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor